[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Creo Medical Group Plc (CREO.LN)

Creo Medical Group Plc (CREO.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Creo Medical Group Plc Beaufort Park Way Unit 2, Creo House Chepstow NP16 5UH GBR

https://www.creomedical.com P: 129-160-6005

Sector:

N/A

INDUSTRY GROUPING:

N/A

Description:

Creo Medical Group PLC is a medical device company engaged in providing services in the field of surgical endoscopy. The company has developed a platform called Croma which is an electrosurgical platform to deliver microwave and bipolar radiofrequency through a single accessory port. The reportable segment of the company is the research and development of electrosurgical medical devices relating to the field of surgical endoscopy. Geographically, the company generates a majority of its revenue from United Kingdom and the rest from Europe and the rest of the world.

Key Statistics

Overview:

Market Capitalization, $K 52,075
Shares Outstanding, K 412,473
% of Insider Shareholders 4.11%
% of Institutional Shareholders 45.19%

Financials:

Annual Sales, $ 4,000 K
Annual Net Income, $ -28,700 K

Growth:

1-Year Return 20.51%
3-Year Return -48.99%
5-Year Return -93.69%
5-Year Revenue Growth 212.26%

Per-Share Information:

Next Earnings Date N/A
Earnings Per Share ttm -0.01
Dividend Payout Ratio 0.00%

CREO.LN Ratios

Ratio
Price/Earnings ttm N/A
Price/Earnings forward N/A
Return-on-Equity % 0.92%
Return-on-Assets % 0.72%
Profit Margin % -717.50%
Debt/Equity 0.05
Price/Sales 10.90
Price/Book 0.86
Book Value/Share 0.15
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.